Details for 2018779167

Up to date per 03.04.2026

Actions

Title / Product Name

VERFAHREN ZUR LYOPHILISIERTEN PHARMAZEUTISCHEN FORMULIERUNG EINES THERAPEUTISCHEN PROTEINS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018779167

EP Publication Number

3681483

E-Number

1492765

Language

PCT Number

US18050305

Publication Date

22.07.2020 A

18.05.2022 B1

Registration Date

18.05.2022

AT Publication Date

15.06.2022

Application Date

10.09.2018

Registration Number

Priorities

15.09.2017

201762559420 P

IPC

A61K 9/19 20060101AFI20210923BHEP

Maximum Duration of Protection

10.09.2038

Owner

Amgen Inc.One Amgen Center Drive Thousand Oaks, California 91320-1799US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

TALLEY, Clea2621 Paseo Yolo Camarillo, California 93010US